Direct activation of human cytotoxic T lymphocytes (CTL) by interleukin (IL
)-18 was observed in a system in which CTL effective against autologous tum
or cells were generated. Peripheral blood mononuclear cells (PBMC) from tum
or-bearing patients, after removal of natural killer (NK) cells, were cultu
red in a medium containing IL-1, -2, -4, and -6, with or without IL-18, and
stimulated with autologous tumor cells. IL-18 increased the activity of th
e CTL and the proportion of autologous CD8(+) T cells present after 28 days
in the induction culture. When purified CD8(+) T cells were cultured in th
e presence of IL-18 and IL-2 for 7 days, the CTL showed enhanced cytotoxic
activity against autologous tumor cells, Moreover, a purified CD8(+) T cell
population, which did not exhibit any apparent cytotoxic activity against
autologous tumor cells, displayed cytotoxic activity after 7-day incubation
with IL-18. These results suggest that IL-18 may be useful to generate aut
ologous CTL in humans and may thereby contribute to adoptive immunotherapy
for tumors.